Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors.Ferreira de Freitas, R., Harding, R.J., Franzoni, I., Ravichandran, M., Mann, M.K., Ouyang, H., Lautens, M., Santhakumar, V., Arrowsmith, C.H., Schapira, M.
(2018) J. Med. Chem. 61: 4517-4527
- PubMed: 29741882
- DOI: 10.1021/acs.jmedchem.8b00258
- Primary Citation of Related Structures:
- PubMed Abstract:
HDAC6 plays a central role in the recruitment of protein aggregates for lysosomal degradation and is a promising target for combination therapy with proteasome inhibitors in multiple myeloma. Pharmacologically displacing ubiquitin from the zinc-finge ...
HDAC6 plays a central role in the recruitment of protein aggregates for lysosomal degradation and is a promising target for combination therapy with proteasome inhibitors in multiple myeloma. Pharmacologically displacing ubiquitin from the zinc-finger ubiquitin-binding domain (ZnF-UBD) of HDAC6 is an underexplored alternative to catalytic inhibition. Here, we present the discovery of an HDAC6 ZnF-UBD-focused chemical series and its progression from virtual screening hits to low micromolar inhibitors. A carboxylate mimicking the C-terminal extremity of ubiquitin, and an extended aromatic system stacking with W1182 and R1155, are necessary for activity. One of the compounds induced a conformational remodeling of the binding site where the primary binding pocket opens up onto a ligand-able secondary pocket that may be exploited to increase potency. The preliminary structure-activity relationship accompanied by nine crystal structures should enable further optimization into a chemical probe to investigate the merit of targeting the ZnF-UBD of HDAC6 in multiple myeloma and other diseases.
Department of Pharmacology and Toxicology , University of Toronto , Toronto , Ontario M5S 1A8 , Canada.,Department of Chemistry, Davenport Chemical Laboratories , University of Toronto , 80 St. George Street , Toronto , Ontario M5S 3H6 Canada.,Structural Genomics Consortium , University of Toronto , MaRS South Tower, Suite 700, 101 College Street , Toronto , Ontario M5G 1L7 , Canada.,Princess Margaret Cancer Centre , University Health Network , Toronto , Ontario , Canada.